arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

IN8BIO, INC.

INAB

$0.94 ▼ -0.02 (-2.48%) at close

7 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

IN8BIO, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -70.5% ↗

FCF / Share $-2.91 ↗

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-19.44M

↑ +36.1% —

FCF / Share Free cash flow per share

$-2.91

↑ +78.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	74.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1605.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	26.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	7.5% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	36.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.4% Weak ↑ Weak Improving Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-94.6% Weak Weak Year-over-year change in net income	-71.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	78.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-1631.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	32.1% Excellent Excellent Year-over-year change in free cash flow	15.1% Good Good Year-over-year change in free cash flow	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
FCF / Net Income (x)	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-70.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-210.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-95.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-99.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	40.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-60.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-145.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-86.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-40.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-70.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-570%)	-210.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1502%)	-120.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-902%)	-125.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-936%)	-38.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-356%)	51.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+244%)	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-4.44	$-17.05	$-1.00	$-1.36	$-1.47	—	—
Free Cash Flow per Share (USD)	$-2.91	$-13.53	$-0.78	$-1.15	$-1.36	—	—
Book Value per Share (USD)	$2.82	$5.99	$0.58	$0.93	$2.03	$-4.40	—
Tangible Book Value per Share (USD)	$2.82	$5.99	$0.58	$0.93	$2.03	$-4.40	—
Basic Weighted Avg Shares (shares)	4.37M	1.78M	29.86M	20.97M	9.97M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$24.72M	$9.49M	$19.23M	$16.41M	$36.72M	$15.57M	—
Total Equity (USD)	$27.56M	$14.48M	$24.94M	$22.73M	$38.18M	$-16.58M	$-9.24M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$1.00M	$976.00K	$962.00K	$147.00K	$89.00K	$88.00K	—
Net Income, GAAP (USD)	$-19.44M	$-30.44M	$-30.01M	$-28.52M	$-14.65M	$-8.56M	—
Operating Cash Flow (USD)	$-12.71M	$-24.15M	$-23.34M	$-24.12M	$-13.51M	$-7.13M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

IN8BIO, INC.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INAB with peers